American Oriental Bioengineering (American Oriental Bioengineering) ROCE % : -24.63% (As of Sep. 2013)

View and export this data going back to 1991. Start your Free Trial

What is American Oriental Bioengineering ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. American Oriental Bioengineering's annualized ROCE % for the quarter that ended in Sep. 2013 was -24.63%.

American Oriental Bioengineering ROCE % Historical Data

The historical data trend for American Oriental Bioengineering's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oriental Bioengineering ROCE % Chart

American Oriental Bioengineering Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

ROCE %

Get a 7-Day Free Trial

15.37

11.90

5.34

-12.71

-14.03

American Oriental Bioengineering Quarterly Data
	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13
ROCE %	Get a 7-Day Free Trial															-20.91	5.40	-24.23	-13.00	-24.63

American Oriental Bioengineering ROCE % Calculation

American Oriental Bioengineering's annualized ROCE % for the fiscal year that ended in Dec. 2012 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2012 )		(A: Dec. 2011 )		(A: Dec. 2012 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2012 )		(A: Dec. 2011 )		(A: Dec. 2012 )
	=	-51.666	/	( ( (564.981 - 168.628)	+	(446.309 - 106.212) )	/ 2 )
	=	-51.666	/	( (396.353	+	340.097)	/ 2 )
	=	-51.666	/	368.225
	=	-14.03 %

American Oriental Bioengineering's ROCE % of for the quarter that ended in Sep. 2013 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2013 )		(Q: Jun. 2013 )		(Q: Sep. 2013 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2013 )		(Q: Jun. 2013 )		(Q: Sep. 2013 )
	=	-75.892	/	( ( (418.805 - 103.819)	+	(427.625 - 126.314) )	/ 2 )
	=	-75.892	/	( ( 314.986	+	301.311 )	/ 2 )
	=	-75.892	/	308.1485
	=	-24.63 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2013) EBIT data.

American Oriental Bioengineering (OTCPK:AOBI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

American Oriental Bioengineering ROCE % Related Terms

Thank you for viewing the detailed overview of American Oriental Bioengineering's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

American Oriental Bioengineering (American Oriental Bioengineering) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Oriental Bioengineering Inc (OTCPK:AOBI) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Liangshuihe First Ave, Beijing E-Town, Economic and Technology Development Area, E-Town, Beijing, CHN, 100176

Website

American Oriental Bioengineering Inc is a manufacturer of pharmaceutical and healthcare products. Its product line encompasses prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products.

Executives

Patti Cosimo J

director

AMERICAN ORIENTAL BIOENGINEERING, INC. 90 PARK AVENUE, 17TH FLOOR NEW YORK NY 10016

American Oriental Bioengineering (American Oriental Bioengineering) Headlines

No Headlines